• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Treatment of ovarian cancer in the Southern Swedish Health Care Region during the five-year period 1974-1978.

作者信息

Sigurdsson K, Johnsson J E, Möller T

出版信息

Ann Chir Gynaecol. 1983;72(5):260-7.

PMID:6318647
Abstract

A total of 555 cases of malignant epithelial ovarian tumour diagnosed in vivo was reported to the Regional Tumour Registry for Southern Sweden, Lund during 1974-1978. Of these 428 (77%) were referred to the Department of Oncology, Lund, which serves the Southern Swedish Health Care Region. Patients not being referred were mostly elderly with advanced tumours. The selection of patients will thus affect the evaluation of the treatment results. The standard surgical procedure was bilateral salpingo-oophorectomy with or without hysterectomy, and infracolic omentectomy. 95% of the patients were treated according to a randomized trial including postoperative chemotherapy, radiotherapy or a combination of both. Preoperative radiotherapy in primarily inoperable patients increased the operability. 34% of all stage IIb, IIc, III, and IV-patients were thus operated or reoperated with only small residual tumour or none at all following surgery. Stage, grade and size of postoperative residual tumour were the most important prognostic factors. The five-year cumulative survival rate for all patients referred to the Department of Oncology was 32%.

摘要

相似文献

1
Treatment of ovarian cancer in the Southern Swedish Health Care Region during the five-year period 1974-1978.
Ann Chir Gynaecol. 1983;72(5):260-7.
2
[Treatment of 63 advanced ovarian carcinomas].[63例晚期卵巢癌的治疗]
Zhonghua Zhong Liu Za Zhi. 1987 Sep;9(5):375-8.
3
Improvement in the outcome of children with germ cell tumors.生殖细胞肿瘤患儿治疗结果的改善。
Pediatr Blood Cancer. 2008 Feb;50(2):250-3. doi: 10.1002/pbc.21268.
4
Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.卵巢非小细胞神经内分泌癌:11例临床病理及免疫组化研究
Am J Surg Pathol. 2007 May;31(5):774-82. doi: 10.1097/01.pas.0000213422.53750.d1.
5
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.预防性卵巢切除术:降低美国上皮性卵巢癌死亡率。一场持续的争论。
Oncologist. 1996;1(5):326-330.
6
[Clinical studies on malignant ovarian tumor--with special reference to therapy and prognosis of epithelial ovarian tumor].
Nihon Sanka Fujinka Gakkai Zasshi. 1984 Apr;36(4):525-30.
7
[Survival in ovarian cancer treated in a gynecological department of a central hospital].[中心医院妇科治疗的卵巢癌患者生存率]
Ugeskr Laeger. 1997 May 12;159(20):3003-9.
8
Consolidation radiotherapy after carboplatin-based chemotherapy in radically operated advanced ovarian cancer.基于卡铂的化疗后对根治性手术的晚期卵巢癌进行巩固放疗。
Gynecol Oncol. 1999 Feb;72(2):215-9. doi: 10.1006/gyno.1998.5184.
9
Carcinoma of the ovary, stages I and II. A prospective randomized study of the effects of postoperative chemotherapy and radiotherapy.卵巢癌,Ⅰ期和Ⅱ期。术后化疗与放疗效果的前瞻性随机研究。
Ann Chir Gynaecol. 1982;71(6):321-9.
10
[Therapy of ovarian stage-Ia carcinoma (review of 103 cases)].
Zentralbl Gynakol. 1975;97(13):791-97.